Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

Autor: Morag C. Martin, Annemieke Walker, Rodger Duffin, Deborah A. Sawatzky, Adriano G. Rossi, Trevor R. Walker, Elvira Crescenzi, Alison Caldicott, Christopher Haslett, Nicola A. Riley, Tara A. Sheldrake, Ian Dransfield, Mohini Gray, John Savill, Hugh J.M. Brady, Magdalena Martinez-Losa, Carol Ward
Jazyk: angličtina
Rok vydání: 2006
Předmět:
Male
Neutrophils
Cell
Apoptosis
Inflammation
Lung injury
Carrageenan
General Biochemistry
Genetics and Molecular Biology

Amino Acid Chloromethyl Ketones
Mice
chemistry.chemical_compound
Cyclin-dependent kinase
Roscovitine
medicine
Animals
Humans
Pyrroles
NF-KAPPA-B
HUMAN NEUTROPHILS
IN-VIVO
DOWN-REGULATION
R-ROSCOVITINE
BACTERIAL LIPOPOLYSACCHARIDE
INDUCIBLE CYCLOOXYGENASE
SELICICLIB CYC202
AGING NEUTROPHILS
MULTIPLE-MYELOMA
Enzyme Inhibitors
Pleurisy
Seliciclib
biology
Caspase 3
Kinase
business.industry
Granulocyte-Macrophage Colony-Stimulating Factor
Azepines
General Medicine
Cyclin-Dependent Kinases
Neoplasm Proteins
medicine.anatomical_structure
Proto-Oncogene Proteins c-bcl-2
chemistry
Purines
Immunology
Cancer research
biology.protein
Myeloid Cell Leukemia Sequence 1 Protein
medicine.symptom
business
CDK inhibitor
Zdroj: Nature medicine
12 (2006): 1056–1064. doi:10.1038/nm1468
info:cnr-pdr/source/autori:Rossi AG; Sawatzky DA; Walker A; Ward C; Sheldrake TA; Riley NA; Caldicott A; Martinez-Losa M; Walker TR; Duffin R; Gray M; Crescenzi E; Martin MC; Brady HJ; Savill JS; Dransfield I; Haslett C./titolo:Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis/doi:10.1038%2Fnm1468/rivista:Nature medicine (Print)/anno:2006/pagina_da:1056/pagina_a:1064/intervallo_pagine:1056–1064/volume:12
DOI: 10.1038/nm1468
Popis: Apoptosis is essential for clearance of potentially injurious inflammatory cells and subsequent efficient resolution of inflammation. Here we report that human neutrophils contain functionally active cyclin-dependent kinases (CDKs), and that structurally diverse CDK inhibitors induce caspase-dependent apoptosis and override powerful anti-apoptosis signals from survival factors such as granulocyte - macrophage colony-stimulating factor (GM-CSF). We show that the CDK inhibitor R-roscovitine (Seliciclib or CYC202) markedly enhances resolution of established neutrophil-dependent inflammation in carrageenan-elicited acute pleurisy, bleomycininduced lung injury, and passively induced arthritis in mice. In the pleurisy model, the caspase inhibitor zVAD-fmk prevents R-roscovitine - enhanced resolution of inflammation, indicating that this CDK inhibitor augments inflammatory cell apoptosis. We also provide evidence that R-roscovitine promotes apoptosis by reducing concentrations of the anti-apoptotic protein Mcl-1. Thus, CDK inhibitors enhance the resolution of established inflammation by promoting apoptosis of inflammatory cells, thereby demonstrating a hitherto unrecognized potential for the treatment of inflammatory disorders.
Databáze: OpenAIRE